Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Prostate Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 93 articles:
HTML format

Single Articles


    May 2008
  1. BOUCHARDY C , Fioretta G, Rapiti E, Verkooijen HM, et al
    Recent trends in prostate cancer mortality show a continuous decrease in several countries.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  2. EVANS S , Metcalfe C, Ibrahim F, Persad R, et al
    Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  3. BASU GD , Azorsa DO, Kiefer JA, Rojas AM, et al
    Functional evidence implicating S100P in prostate cancer progression.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


    April 2008
  4. KIKUNO N , Shiina H, Urakami S, Kawamoto K, et al
    Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  5. DEEP G , Oberlies NH, Kroll DJ, Agarwal R, et al
    Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
    Int J Cancer. 2008;123:41-50.
    PubMed     Related articles    Abstract available


  6. CAI Y , Lee YF, Li G, Liu S, et al
    A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  7. VALTA MP , Tuomela J, Bjartell A, Valve E, et al
    FGF-8 is involved in bone metastasis of prostate cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  8. BHATIA B , Multani AS, Patrawala L, Chen X, et al
    Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT.
    Int J Cancer. 2008;122:1483-95.
    PubMed     Related articles    Abstract available


    March 2008
  9. BEEBE-DIMMER JL , Levin AM, Ray AM, Zuhlke KA, et al
    Chromosome 8q24 markers: Risk of early-onset and familial prostate cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  10. NABHA SM , Santos EB, Yamamoto HA, Belizi A, et al
    Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  11. VAARALA MH , Mattila H, Ohtonen P, Tammela TL, et al
    The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  12. BARTZ R , Zhou J, Hsieh JT, Ying Y, et al
    Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo.
    Int J Cancer. 2008;122:520-5.
    PubMed     Related articles    Abstract available


  13. LAITINEN S , Martikainen PM, Tolonen T, Isola J, et al
    EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
    Int J Cancer. 2008;122:595-602.
    PubMed     Related articles    Abstract available


    January 2008
  14. HADASCHIK BA , Ettinger S, Sowery RD, Zoubeidi A, et al
    Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  15. PARMIGIANI RB , Bettoni F, Grosso DM, Lopes A, et al
    Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  16. HOWARD EW , Lee DT, Chiu YT, Chua CW, et al
    Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  17. WEISS JM , Huang WY, Rinaldi S, Fears TR, et al
    Endogenous sex hormones and the risk of prostate cancer: A prospective study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


  18. WANG Z , Hu H, Li G, Lee HJ, et al
    Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
    Int J Cancer. 2008;122:15-24.
    PubMed     Related articles    Abstract available


    December 2007
  19. RANDI G , Pelucchi C, Negri E, Talamini R, et al
    Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers.
    Int J Cancer. 2007;121:2748-52.
    PubMed     Related articles    Abstract available


  20. BELL DW , Kim SH, Godwin AK, Schiripo TA, et al
    Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
    Int J Cancer. 2007;121:2661-7.
    PubMed     Related articles    Abstract available


  21. SRIVASTAVA M , Torosyan Y, Raffeld M, Eidelman O, et al
    ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
    Int J Cancer. 2007;121:2628-36.
    PubMed     Related articles    Abstract available


    November 2007
  22. THEURILLAT JP , Zurrer-Hardi U, Varga Z, Barghorn A, et al
    Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  23. FLADEBY C , Gupta SN, Barois N, Lorenzo PI, et al
    Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  24. QIAN X , Ara G, Mills E, Larochelle WJ, et al
    Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  25. WEGIEL B , Bjartell A, Culig Z, Persson JL, et al
    Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  26. WIEBALK K , Schmezer P, Kropp S, Chang-Claude J, et al
    In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy.
    Int J Cancer. 2007;121:2340-5.
    PubMed     Related articles    Abstract available


    October 2007
  27. GRAESER R , Chung DE, Esser N, Moor S, et al
    Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  28. LAMOUREUX F , Ory B, Battaglia S, Pilet P, et al
    Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  29. ROUPRET M , Hupertan V, Catto JW, Yates DR, et al
    Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  30. ZHIGANG Z , Wenlu S
    Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  31. KIEMENEY LA , Broeders MJ, Pelger M, Kil PJ, et al
    Screening for prostate cancer in Dutch hereditary prostate cancer families.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  32. TAKAHASHI N , Watanabe Y, Maitani Y, Yamauchi T, et al
    p-dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  33. SORENSEN KD , Borre M, Orntoft TF, Dyrskjot L, et al
    Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  34. MAHAJAN R , Blair A, Coble J, Lynch CF, et al
    Carbaryl exposure and incident cancer in the Agricultural Health Study.
    Int J Cancer. 2007;121:1799-805.
    PubMed     Related articles    Abstract available


  35. VAN VELDHUIZEN PJ , Ray G, Banerjee S, Dhar G, et al
    2-Methoxyestradiol modulates beta-catenin in prostate cancer cells: A possible mediator of 2-methoxyestradiol-induced inhibition of cell growth.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  36. MAKINEN T , Karhunen P, Aro J, Lahtela J, et al
    Assessment of causes of death in a prostate cancer screening trial.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text


  37. SCHULTZ M , Parzinger H, Posdnjakov DV, Chikisheva TA, et al
    Oldest known case of metastasizing prostate carcinoma diagnosed in the skeleton of a 2,700-year-old Scythian king from Arzhan (Siberia, Russia).
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  38. KANDA H , Ishii K, Ogura Y, Imamura T, et al
    Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text


  39. PENG L , Wang J, Malloy PJ, Feldman D, et al
    The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    September 2007
  40. TANG D , Liu JJ, Bock CH, Neslund-Dudas C, et al
    Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate.
    Int J Cancer. 2007;121:1319-24.
    PubMed     Related articles    Abstract available


  41. DENG X , He G, Levine A, Cao Y, et al
    Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  42. FUJIMURA T , Shinohara Y, Tissot B, Pang PC, et al
    Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  43. NELIUS T , Filleur S, Yemelyanov A, Budunova I, et al
    Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.
    Int J Cancer. 2007;121:999-1008.
    PubMed     Related articles    Abstract available


    August 2007
  44. ELLINGER J , Bastian PJ, Haan KI, Heukamp LC, et al
    Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  45. SUTCLIFFE S , Giovannucci E, Isaacs WB, Willett WC, et al
    Acne and risk of prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  46. LIN JF , Xu J, Tian HY, Gao X, et al
    Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  47. LUNDQVIST E , Kaprio J, Verkasalo PK, Pukkala E, et al
    Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins.
    Int J Cancer. 2007;121:810-8.
    PubMed     Related articles    Abstract available


  48. MOLS F , Helfenrath KA, Vingerhoets AJ, Coebergh JW, et al
    Increased health care utilization among long-term cancer survivors compared to the average Dutch population: a population-based study.
    Int J Cancer. 2007;121:871-7.
    PubMed     Related articles    Abstract available


  49. YOKOKAWA J , Bera TK, Palena C, Cereda V, et al
    Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4).
    Int J Cancer. 2007;121:595-605.
    PubMed     Related articles    Abstract available


    July 2007
  50. VICKERS AJ , Ulmert D, Serio AM, Bjork T, et al
    The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  51. GONDOS A , Arndt V, Holleczek B, Stegmaier C, et al
    Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
    Int J Cancer. 2007;121:395-400.
    PubMed     Related articles    Abstract available


  52. DE GIOVANNI C , Croci S, Nicoletti G, Landuzzi L, et al
    Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
    Int J Cancer. 2007;121:88-94.
    PubMed     Related articles    Abstract available


    June 2007
  53. WEISS JM , Huang WY, Rinaldi S, Fears TR, et al
    IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  54. BRAKENHIELM E , Burton JB, Johnson M, Chavarria N, et al
    Modulating metastasis by a lymphangiogenic switch in prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  55. SHUKLA S , Maclennan GT, Hartman DJ, Fu P, et al
    Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    May 2007
  56. LAPOUGE G , Erdmann E, Marcias G, Jagla M, et al
    Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation-A new paradigm for cooperation among prostate tumor cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  57. GONZALEZ-MORENO O , Segura V, Serrano D, Nguewa P, et al
    Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  58. THOMAS-KASKEL AK , Waller CF, Schultze-Seemann W, Veelken H, et al
    Immunotherapy with dendritic cells for prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  59. TRAVIS RC , Key TJ, Allen NE, Appleby PN, et al
    Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  60. CATENA R , Muniz-Medina V, Moralejo B, Javierre B, et al
    Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis.
    Int J Cancer. 2007;120:2096-109.
    PubMed     Related articles    Abstract available


  61. PARK SY , Murphy SP, Wilkens LR, Henderson BE, et al
    Fat and meat intake and prostate cancer risk: The multiethnic cohort study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    April 2007
  62. GALLINA A , Karakiewicz PI, Hutterer GC, Chun FK, et al
    Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  63. GIOVANNUCCI E , Liu Y, Platz EA, Stampfer MJ, et al
    Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  64. ENDSLEY MP , Aggarwal N, Isbell MA, Wheelock CE, et al
    Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  65. CAREY AM , Pramanik R, Nicholson LJ, Dew TK, et al
    Ras-MEK-ERK signaling cascade regulates androgen receptor element-inducible gene transcription and DNA synthesis in prostate cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  66. SKYTT A , Thysell E, Stattin P, Stenman UH, et al
    SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    March 2007
  67. LU Y , Xiao G, Galson DL, Nishio Y, et al
    PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  68. RAFFOUL JJ , Banerjee S, Che M, Knoll ZE, et al
    Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  69. REED MJ , Karres N, Eyman D, Cruz A, et al
    The effects of aging on tumor growth and angiogenesis are tumor-cell dependent.
    Int J Cancer. 2007;120:753-60.
    PubMed     Related articles    Abstract available


  70. FUJIMURA T , Takahashi S, Urano T, Kumagai J, et al
    Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  71. STOCKS T , Lukanova A, Rinaldi S, Biessy C, et al
    Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  72. MITROU PN , Albanes D, Weinstein SJ, Pietinen P, et al
    A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland).
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    January 2007
  73. LI GX , Hu H, Jiang C, Schuster T, et al
    Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  74. BERG A , Berner A, Lilleby W, Bruland OS, et al
    Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  75. FLAIG TW , Su LJ, Harrison G, Agarwal R, et al
    Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  76. SUTCLIFFE S , Giovannucci E, Leitzmann MF, Rimm EB, et al
    A prospective cohort study of red wine consumption and risk of prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  77. SCHWARZENBACH H , Chun FK, Lange I, Carpenter S, et al
    Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  78. PINTO JT , Sinha R, Papp K, Facompre ND, et al
    Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  79. STEUBER T , Vickers A, Haese A, Kattan MW, et al
    Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  80. ATLASI Y , Mowla SJ, Ziaee SA, Bahrami AR, et al
    OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    December 2006
  81. DERYCKE L , De Wever O, Stove V, Vanhoecke B, et al
    Soluble N-cadherin in human biological fluids.
    Int J Cancer. 2006;119:2895-900.
    PubMed     Related articles    Abstract available


  82. SCHMITZ M , Grignard G, Margue C, Dippel W, et al
    Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  83. CHMELAR R , Buchanan G, Need EF, Tilley W, et al
    Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    November 2006
  84. HAYES VM , Severi G, Padilla EJ, Morris HA, et al
    5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  85. BISOFFI M , Heaphy CM, Griffith JK
    Telomeres: prognostic markers for solid tumors.
    Int J Cancer. 2006;119:2255-60.
    PubMed     Related articles    Abstract available


  86. JOHANSSON M , McKay JD, Stattin P, Canzian F, et al
    Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    October 2006
  87. HEDELIN M , Chang ET, Wiklund F, Bellocco R, et al
    Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  88. CHO NY , Choi M, Kim BH, Cho YM, et al
    BRAF and KRAS mutations in prostatic adenocarcinoma.
    Int J Cancer. 2006;119:1858-62.
    PubMed     Related articles    Abstract available


  89. SCELO G , Boffetta P, Autier P, Hemminki K, et al
    Associations between ocular melanoma and other primary cancers: An international population-based study.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  90. NILSEN TI , Romundstad PR, Vatten LJ
    Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study).
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  91. ALI K , Gunnar A, Jan-Erik D, Hans L, et al
    PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  92. MIMEAULT M , Venkatraman G, Johansson SL, Moore E, et al
    Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  93. GRANT JF , Iwasawa T, Sinn HW, Siemens DR, et al
    Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: